During an upper respiratory infection, when is a person contagious?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

When You Are Contagious During an Upper Respiratory Infection

You are most contagious starting the day before symptoms begin through approximately 5 days after illness onset in adults (up to 7 days in children), with peak infectiousness occurring soon after symptoms develop. 1, 2

Timing of Contagiousness

Peak Infectious Period

  • Maximum contagiousness: Begins 1 day before symptoms appear and continues through the first 5 days of illness in adults 2
  • Children remain infectious longer: Up to 7 days after symptom onset 1
  • Viral load peaks: Days 4-6 after illness onset, then steadily declines 1

Incubation Period

The time from exposure to symptom development is typically:

  • Most common: 48-72 hours (2-3 days)
  • Range: 24 hours to 7 days 1

Pre-Symptomatic Transmission

  • Spread before symptoms develop has been rarely recorded and represents only a small minority of all transmissions 1
  • However, you can be infectious starting the day before symptoms appear 2

Practical Isolation Guidance

For General Public

Consider yourself contagious for at least 7 days from symptom onset (counting from when the second eye becomes involved if applicable for conjunctivitis) 3, 4. Some evidence suggests extending this to 10-14 days for complete safety, as virus recovery becomes difficult after 7-10 days but may persist longer 3, 4.

For High-Risk Professions

Healthcare workers and childcare providers should be especially cautious about avoiding contact with others during the contagious period, as they have high potential for transmission 3, 4.

Transmission Mechanisms

Upper respiratory infections spread primarily through:

  • Large respiratory droplets from coughing and sneezing
  • Direct contact (e.g., shaking hands after touching nose/mouth)
  • Indirect contact with contaminated surfaces (fomites) 1

Risk Factors for Transmission

  • Being within 1 meter of an infected person who is coughing/sneezing
  • Touching contaminated tissues or surfaces
  • Contact with hands of infectious persons 1

Important Caveats

Immunocompromised individuals can shed virus for weeks, making them contagious for much longer periods 2. This population requires individualized assessment beyond the standard 5-7 day window.

The evidence consistently shows that viral shedding and infectiousness decline steadily after the first 5 days, though some viral excretion may continue 1. The practical recommendation of 7-10 days provides a safety margin while balancing the need to return to normal activities.

Related Questions

What is the appropriate management of nasal congestion in adult patients with a viral upper respiratory infection?
What medication should be prescribed for a 36-year-old woman with no comorbidities who has a viral upper respiratory infection presenting with three days of nasal congestion and cold symptoms?
What is the most likely diagnosis for a 6‑month‑old full‑term infant with recent mild to moderate upper respiratory infection symptoms, frequent cough, tachypnea (respiratory rate 48/min), bilateral expiratory wheezes, mild crackles, clear nasal discharge, low‑grade fever (37.7 °C), oxygen saturation 96% on room air, well‑hydrated, breastfeeding without difficulty, attending family day care three times weekly, and no prior respiratory or cardiac disease?
What is the recommended management for a 35-year-old female who had an upper respiratory infection two weeks ago and now presents with a two-day history of itchy throat, dry cough, chills, and body aches?
Is a cough with normal lung auscultation indicative of an upper respiratory tract infection?
When do the ankle growth plates (physes) close?
Which clinical findings are characteristic of spondyloarthritides: peripheral oligoarthritis, iridocyclitis (acute anterior uveitis), acute monoarthritis of the first metatarsophalangeal joint, mechanical-type low back pain, or Achilles tendinitis?
What is the appropriate dosing, administration, monitoring, and contraindications for Lokelma (sodium polystyrene sulfonate) in treating hyperkalaemia?
What is the recommended dosage of Proplex (human factor IX complex) for treating an acute bleeding episode in an adult with hemophilia B?
Which drug can be used to induce sweating in a multiple trauma patient (MTP)?
What medication should be prescribed for a 15-year-old with substance use disorder, currently on Abilify (aripiprazole) 2 mg and Lexapro (escitalopram) 20 mg, who is irritable in an inpatient psychiatric setting?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.